N-(5-fluoro-2-adamantyl)-4-[4-(4-methylsulfonylpiperazin-1-yl)phenyl]-2,3-dihydroquinoxaline-1-carboxamide

C30H38FN5O3S — CID 58102053

IUPACN-(5-fluoro-2-adamantyl)-4-[4-(4-methylsulfonylpiperazin-1-yl)phenyl]-2,3-dihydroquinoxaline-1-carboxamide
SMILESCS(=O)(=O)N1CCN(c2ccc(N3CCN(C(=O)NC4C5CC6CC4CC(F)(C6)C5)c4ccccc43)cc2)CC1
InChIInChI=1S/C30H38FN5O3S/c1-40(38,39)34-12-10-33(11-13-34)24-6-8-25(9-7-24)35-14-15-36(27-5-3-2-4-26(27)35)29(37)32-28-22-16-21-17-23(28)20-30(31,18-21)19-22/h2-9,21-23,28H,10-20H2,1H3,(H,32,37)
InChIKeyKHXOFQXFPUAWTD-UHFFFAOYSA-N
MW567.73 g/mol
LogP4.35
Rot. Bonds4

About N-(5-fluoro-2-adamantyl)-4-[4-(4-methylsulfonylpiperazin-1-yl)phenyl]-2,3-dihydroquinoxaline-1-carboxamide

N-(5-fluoro-2-adamantyl)-4-[4-(4-methylsulfonylpiperazin-1-yl)phenyl]-2,3-dihydroquinoxaline-1-carboxamide (PubChem CID 58102053) has the molecular formula C30H38FN5O3S and a molecular weight of 567.73 g/mol. Its IUPAC name is N-(5-fluoro-2-adamantyl)-4-[4-(4-methylsulfonylpiperazin-1-yl)phenyl]-2,3-dihydroquinoxaline-1-carboxamide.

Molecular Properties

Compound NameN-(5-fluoro-2-adamantyl)-4-[4-(4-methylsulfonylpiperazin-1-yl)phenyl]-2,3-dihydroquinoxaline-1-carboxamide
PubChem CID58102053
Molecular FormulaC30H38FN5O3S
Molecular Weight567.73 g/mol
Exact Mass567.27
IUPAC NameN-(5-fluoro-2-adamantyl)-4-[4-(4-methylsulfonylpiperazin-1-yl)phenyl]-2,3-dihydroquinoxaline-1-carboxamide
SMILESCS(=O)(=O)N1CCN(c2ccc(N3CCN(C(=O)NC4C5CC6CC4CC(F)(C6)C5)c4ccccc43)cc2)CC1
InChIInChI=1S/C30H38FN5O3S/c1-40(38,39)34-12-10-33(11-13-34)24-6-8-25(9-7-24)35-14-15-36(27-5-3-2-4-26(27)35)29(37)32-28-22-16-21-17-23(28)20-30(31,18-21)19-22/h2-9,21-23,28H,10-20H2,1H3,(H,32,37)
InChIKeyKHXOFQXFPUAWTD-UHFFFAOYSA-N
XLogP4.35
TPSA76.20 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds4
Heavy Atoms40
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500567.73
LogP ≤ 54.35
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_A(478)', 'substructure': 'N/A'}

Analyze N-(5-fluoro-2-adamantyl)-4-[4-(4-methylsulfonylpiperazin-1-yl)phenyl]-2,3-dihydroquinoxaline-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-(5-fluoro-2-adamantyl)-4-[4-(4-methylsulfonylpiperazin-1-yl)phenyl]-2,3-dihydroquinoxaline-1-carboxamide?
The IUPAC name of N-(5-fluoro-2-adamantyl)-4-[4-(4-methylsulfonylpiperazin-1-yl)phenyl]-2,3-dihydroquinoxaline-1-carboxamide (CID 58102053) is N-(5-fluoro-2-adamantyl)-4-[4-(4-methylsulfonylpiperazin-1-yl)phenyl]-2,3-dihydroquinoxaline-1-carboxamide.
What is the SMILES notation for N-(5-fluoro-2-adamantyl)-4-[4-(4-methylsulfonylpiperazin-1-yl)phenyl]-2,3-dihydroquinoxaline-1-carboxamide?
The canonical SMILES for N-(5-fluoro-2-adamantyl)-4-[4-(4-methylsulfonylpiperazin-1-yl)phenyl]-2,3-dihydroquinoxaline-1-carboxamide is CS(=O)(=O)N1CCN(c2ccc(N3CCN(C(=O)NC4C5CC6CC4CC(F)(C6)C5)c4ccccc43)cc2)CC1.
What is the InChIKey of N-(5-fluoro-2-adamantyl)-4-[4-(4-methylsulfonylpiperazin-1-yl)phenyl]-2,3-dihydroquinoxaline-1-carboxamide?
The InChIKey is KHXOFQXFPUAWTD-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H38FN5O3S/c1-40(38,39)34-12-10-33(11-13-34)24-6-8-25(9-7-24)35-14-15-36(27-5-3-2-4-26(27)35)29(37)32-28-22-16-21-17-23(28)20-30(31,18-21)19-22/h2-9,21-23,28H,10-20H2,1H3,(H,32,37).
What are the key properties of N-(5-fluoro-2-adamantyl)-4-[4-(4-methylsulfonylpiperazin-1-yl)phenyl]-2,3-dihydroquinoxaline-1-carboxamide?
N-(5-fluoro-2-adamantyl)-4-[4-(4-methylsulfonylpiperazin-1-yl)phenyl]-2,3-dihydroquinoxaline-1-carboxamide has a molecular weight of 567.73 g/mol, XLogP of 4.35, 4 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-(5-fluoro-2-adamantyl)-4-[4-(4-methylsulfonylpiperazin-1-yl)phenyl]-2,3-dihydroquinoxaline-1-carboxamide is sourced from PubChem (CID 58102053), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).